Revolade 25Mg 28 TABLET
Revolade 25Mg 28 Tablets - Comprehensive Overview
Revolade 25mg Tablets are a crucial medication designed for the treatment of various conditions associated with low platelet counts. Sourced from trusted pharmacies like Nahdi Online and available on platforms such as , this product provides an essential therapeutic option for patients requiring platelet count elevation. Revolade, with its active ingredient Eltrombopag, is a thrombopoietin receptor agonist that stimulates the production of platelets in the bone marrow, significantly reducing the risk of bleeding episodes and improving overall patient quality of life.
This medication is primarily used to address chronic immune (idiopathic) thrombocytopenia (ITP) in adults and children 1 year and older who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for the treatment of severe aplastic anemia (SAA) in patients who have had an insufficient response to immunosuppressive therapy, and for thrombocytopenia in patients with chronic hepatitis C virus (HCV) infection to allow the initiation and maintenance of interferon-based therapy.
Benefits of Revolade 25Mg Tablets
- Significantly increases platelet count, reducing the risk of bleeding.
- Helps manage chronic immune (idiopathic) thrombocytopenia (ITP).
- Offers a vital treatment for severe aplastic anemia (SAA).
- Facilitates interferon-based therapy for chronic hepatitis C patients with thrombocytopenia.
- May allow for the reduction or discontinuation of concomitant medications for ITP.
How to Use Revolade 25Mg Tablets
- Always take Revolade exactly as prescribed by your doctor.
- The usual starting dose varies depending on the condition being treated.
- Take Revolade on an empty stomach, at least one hour before or two hours after meals.
- Avoid taking Revolade with food or drink containing calcium (dairy products, fortified juices) within four hours before or after the dose.
- Swallow the tablets whole with water; do not crush, break, or chew them.
- Your doctor will monitor your platelet count and liver function regularly and adjust your dose as needed.
Caution & Warnings
Liver Function: Regular monitoring of liver function tests is crucial as Revolade can cause liver toxicity.
Thrombotic/Thromboembolic Complications: An increased risk of blood clots may occur, especially in patients with chronic liver disease.
Bone Marrow Changes: Patients may experience changes in their bone marrow, including an increase in reticulin formation. Regular bone marrow examinations may be necessary.
Cataracts: Cataracts have been observed in some patients treated with Revolade; ophthalmological examinations may be recommended.
Not a Substitute: Revolade is not indicated for the treatment of myelodysplastic syndromes (MDS) or other causes of thrombocytopenia.
Pregnancy & Breastfeeding: Not recommended during pregnancy or breastfeeding unless clearly necessary and under strict medical supervision.
Drug Interactions: Inform your doctor about all medications, supplements, and herbal products you are taking.
Ingredients
Active Ingredient: Eltrombopag (as eltrombopag olamine) 25 mg.
Excipients: Include but are not limited to microcrystalline cellulose, magnesium stearate, mannitol, povidone, sodium starch glycolate, and film coating components (e.g., hypromellose, titanium dioxide, macrogol, iron oxide yellow).
Product Details
Form: Film-coated Tablets
Strength: 25 mg Eltrombopag
Pack Size: 28 Tablets
Legal Status: Prescription Only Medicine (POM)
| Gtin | 2307257814 |
|---|---|
| Recommended Sale Price | 2469.8 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| SFDA Reg. No | 2307257814 |
| IBC | 2307257814 |
| Drug Type | Prescription |
| Scientific Name | Eltrombopag |
| Strength | 25 |
| Strength Unit | mg |
| Form | Tablet |
| Admin Route | Oral |
| Size | 28 |
| Size Unit | Tablets |
| Package Types | Blister pack, Carton |
| Package Size | 28 Tablets |
| Storage conditions | Store below 30°C, protect from moisture and light. |
| Refrigerator Storage | No |
